MMJ Group Holdings Ltd Stock Market Press Releases and Company Profile
Investment in MediPharm Labs Inc
Investment in MediPharm Labs Inc

Perth, July 2, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (googlechartASX:MMJ) ("MMJ") has invested CAD$5 million for a 6.9% basic shareholding in privately-held MediPharm Labs Inc ("MediPharm") as part of their CAD$22.3 million funding round.

Description of MediPharm

Based in Barrie ON, Canada, MediPharm:

- owns Canada's largest medical cannabis oil production facility that will support 100,000kg of annual dry cannabis processing

- is a Access to Cannabis for Medical Purposes Regulations (ACMPR) Licensed Producer for the production of cannabis oil and expects to receive a Sales Licence later this year

- uses innovative extraction technologies that create superior products designed for specific patient solutions

- has manufacturing and distribution partnerships with proven patented formulators

- is strongly positioned to capitalise on Canadian medical cannabis oil market sales growth, both for domestic patients and for export

- owns a majority share in MediPharm Labs Australia, based in Wonthaggi Victoria, whose cannabis manufacturing license application has been lodged

For further details please visit medipharmlabs.com

MMJ CEO comments

MMJ's CEO Jason Conroy commented that "As Canada's largest medical cannabis oil production facility and with a strategic presence in Australia, MediPharm is strongly positioned to capitalise on growth opportunities both in Canada and overseas."


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/

https://plus.google.com/112611716213432048650/posts https://www.youtube.com/channel/UCkDxKKC_fe2TdZfeVSpPVhw abnnewswire.com 


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 10) (Last 30 Days: 33) (Since Published: 9358)